News

Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc.
Top Analyst Reports for Microsoft, Alibaba & Merck
MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.
Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) is one of the stocks Jim Cramer recently discussed. Verona Pharma plc ...
Pharmabiz16h
Merck Animal Health’s Bravecto Quantum receives US FDA approval to treat and protect dogs from fleas and ticks
Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...
Shareholders From 30 Major Corporations Vote Unanimously Against Anti-DEI Policies
Majority of anti-DEI shareholder votes came in between 98% and 99%, proving their stance on the initiatives that are under ...